Table 3.

Incidence rate per 100 person-years with 95% confidence intervals of bone mineral density testing in subgroup of patients with cancer and non-cancer controls who developed an incident fracture.

	0–1 year post fracture	1–2 years post fracture	2–3 years post fracture	3–5 years post fracture
All cancer
Cancer	3.04 (2.90, 3.19) n = 7745	1.61 (1.50, 1.71) n = 6819	1.23 (1.13, 1.32) n = 6513	1.47 (1.37, 1.58) n = 5914
Non-cancer control	2.66 (2.54, 2.79) n = 7745	1.07 (0.99, 1.15) n = 7583	0.95 (0.88, 1.03) n = 7472	1.07 (0.97, 1.13) n = 7192
Solid cancer
Solid cancer	3.11 (3.08, 3.39) n = 6558	1.65 (1.53, 1.77) n = 5770	1.25 (1.15, 1.36) n = 5513	1.52 (1.40, 1.64) n = 5016
Non-cancer control	2.69 (2.53, 2.81) n = 6558	1.10 (1.01, 1.19) n = 6431	0.95 (0.87, 1.04) n = 6341	1.09 (1.00, 1.18) n = 6107
Haematologic cancer
Haematologic cancer	2.68 (2.31, 3.04) n = 1170	1.23 (0.98, 1.47) n = 1036	0.96 (0.74, 1.18) n = 989	1.15 (0.90, 1.40) n = 895
Non-cancer control	2.47 (2.15, 2.79) n = 1170	0.84 (0.65, 1.03) n = 1144	0.90 (0.71, 1.09) n = 1121	0.88 (0.69, 1.08) n = 1069